Clinical Trial Update: Enhanced Provision of Male Circumcision (MC) for HIV Prevention, Rakai, Uganda [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on enhanced provision of neonatal male circumcision as an HIV prevention strategy in Rakai, Uganda; trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Neonatal Male Circumcision | Phase 2, Phase 3 | Status: COMPLETED